4-[4-[(2R)-2-(4-fluoroindol-1-yl)propanoyl]cyclohexyl]-N-pyrimidin-4-ylbenzenesulfonamide
C27H27FN4O3S — CID 58215094
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[4-[(2R)-2-(4-fluoroindol-1-yl)propanoyl]cyclohexyl]-N-pyrimidin-4-ylbenzenesulfonamide
4-[4-[(2R)-2-(4-fluoroindol-1-yl)propanoyl]cyclohexyl]-N-pyrimidin-4-ylbenzenesulfonamide (PubChem CID 58215094) has the molecular formula C27H27FN4O3S and a molecular weight of 506.60 g/mol. Its IUPAC name is 4-[4-[(2R)-2-(4-fluoroindol-1-yl)propanoyl]cyclohexyl]-N-pyrimidin-4-ylbenzenesulfonamide.
Molecular Properties
| Compound Name | 4-[4-[(2R)-2-(4-fluoroindol-1-yl)propanoyl]cyclohexyl]-N-pyrimidin-4-ylbenzenesulfonamide |
|---|---|
| PubChem CID | 58215094 |
| Molecular Formula | C27H27FN4O3S |
| Molecular Weight | 506.60 g/mol |
| Exact Mass | 506.18 |
| IUPAC Name | 4-[4-[(2R)-2-(4-fluoroindol-1-yl)propanoyl]cyclohexyl]-N-pyrimidin-4-ylbenzenesulfonamide |
| SMILES | C[C@H](C(=O)C1CCC(c2ccc(S(=O)(=O)Nc3ccncn3)cc2)CC1)n1ccc2c(F)cccc21 |
| InChI | InChI=1S/C27H27FN4O3S/c1-18(32-16-14-23-24(28)3-2-4-25(23)32)27(33)21-7-5-19(6-8-21)20-9-11-22(12-10-20)36(34,35)31-26-13-15-29-17-30-26/h2-4,9-19,21H,5-8H2,1H3,(H,29,30,31)/t18-,19?,21?/m1/s1 |
| InChIKey | YDSZDALODFZNIM-LWEYNCJUSA-N |
| XLogP | 5.48 |
| TPSA | 93.95 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 506.60 |
| LogP ≤ 5 | 5.48 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58215094 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.